Autobio Diagnostics Co., Ltd. (SHA:603658)

China flag China · Delayed Price · Currency is CNY
38.82
-0.15 (-0.38%)
Oct 24, 2025, 2:45 PM CST
-0.38%
Market Cap22.19B
Revenue (ttm)4.32B
Net Income (ttm)1.15B
Shares Out571.42M
EPS (ttm)2.00
PE Ratio19.41
Forward PE17.95
Dividend1.26 (3.24%)
Ex-Dividend DateMay 26, 2025
Volume1,243,500
Average Volume2,411,459
Open38.95
Previous Close38.97
Day's Range38.72 - 39.00
52-Week Range36.49 - 47.82
Beta-0.12
RSI42.55
Earnings DateOct 30, 2025

About Autobio Diagnostics

Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products in China and internationally. The company offers immunoassay, biochemistry, and microbiology products; reagents and instruments; and technical and support, and training services, as well as engages in biology research and development activities. Its immunoassay products consist of AutoLumo S900 and AutoLumo A1860 that provides user experience for small and medium size labs; AutoLumo A6200/A6600, an auto... [Read more]

Sector Healthcare
Founded 1998
Employees 5,773
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603658
Full Company Profile

Financial Performance

In 2024, Autobio Diagnostics's revenue was 4.47 billion, an increase of 0.62% compared to the previous year's 4.44 billion. Earnings were 1.19 billion, a decrease of -1.89%.

Financial Statements

News

There is no news available yet.